Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey-Reference-Cited by-同舟云学术

Severe adverse effects of bromocriptine in lactation inhibition: a pharmacovigilance survey

Published:2015-03-11 Issue:9 Volume:122 Page:1244-1251
ISSN:1470-0328
Container-title:BJOG: An International Journal of Obstetrics & Gynaecology
language:en
Short-container-title:BJOG: Int J Obstet Gy

Author:

Bernard N¹,Jantzem H²,Becker M³,Pecriaux C⁴,Bénard-Laribière A⁵,Montastruc JL⁶,Descotes J¹,Vial T¹,

Affiliation:

1. Centre de Pharmacovigilance - Centre Antipoison; Hospices Civils de Lyon; Lyon France

2. Centre de Pharmacovigilance; CHU de Brest; Hôpital de la Cavale Blanche; Brest France

3. Centre de Pharmacovigilance; Hôpital Central; Nancy France

4. Centre de Pharmacovigilance; Groupe Hospitalier Cochin; Bâtiment Lavoisier; Paris France

5. Centre de Pharmacovigilance; CHU de Bordeaux; Bordeaux France

6. Service de Pharmacologie Médicale et Clinique; Centre Midi-Pyrénées de Pharmacovigilance; de Pharmacoépidémiologie et d'Informations sur le Médicament; équipe de pharmacoépidémiologie; UMR INSERM 1027; Faculté de Médecine; Centre Hospitalo-universitaire; Toulouse France

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/1471-0528.13352/fullpdf

Reference66 articles.

1. Bromocriptine and lactation suppression: are the risks acceptable?;De Jong Van Den Berg;Pharm World Sci,1995

2. À propos d'une enquête de pharmacovigilance sur la bromocriptine utilisée dans l'inhibition de la lactation;Graille;La Lettre du pharmacologue,1995

3. Breastfeeding rates in maternity units and at 1 month. Results from the EPIFANE survey, France, 2012;Salanave;Bull Epidemiol Hebd,2013

4. Promotion of Breastfeeding in Europe project. Protection, promotion and support of breast-feeding in Europe: current situation;Cattaneo;Public Health Nutr,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficiency of cabergoline vs pyridoxine for lactation inhibition—a randomized controlled trial;American Journal of Obstetrics and Gynecology;2023-10

2. Therapeutic potential of lipid nanosystems for the treatment of Parkinson’s disease;Ageing Research Reviews;2023-08

3. Neuropsychiatric features of Parkinson's disease in the era prior to the use of dopaminergic therapies;Cognitive Neuropsychiatry;2023-05-12

4. Bromocriptine therapy: Review of mechanism of action, safety and tolerability;Clinical and Experimental Pharmacology and Physiology;2022-06-22

5. References;Breastfeeding;2022